Overall, TNF-α, IL-1β, and IL-6 could be valid molecular targets in light of their deregulation in autoimmune diseases and their involvement as activators of transduction cascades involving ADAM17 [121,122,123,124]. Here, ADAM17 is linked to autoimmune disease.